FDA halts coronavirus testing program backed by Bill Gates
nytimes.com
nytimes.com
Is Bill Gates somehow involved in this decision? Because one would hope that a private individual would not be have undue influence on public health organizations' decisions, especially when he has much of his wealth invested in the very industry that is likely to be affected by the results of this Coronavirus study. It's an overt conflict of interest.
I doubt the FDA's decision had anything to do with the Gates connection, but most study rejections don't get articles in the NYT. His backing is why it's "news," he spend/gives millions to the press to ensure it.
Edit: to say "halted".
I don't really see the point of most of the stories about various ongoing tests. Until something is shown to be effective, what benefit do we get from learning all these details?
No, it's news because the FDA is haulting COVID testing over utterly stupid bureaucracy when we need massively ramped up COVID testing and SCAN/Seattle Flu Study are actually providing quality home tests at scale.
This stands in stark contrast to the hundreds of poor quality home antibody tests the FDA has approved with almost no oversight. It seems inconsistent with the need to cut red tape to fight COVID.
It's not utterly stupid, diagnostic testing adds some amount of bias in the results. The quality of these home tests needs to be proven.
How does it add bias? Also, this is not the FDA's stated concern.
> The quality of these home tests needs to be proven.
They have been. That data has been submitted to the FDA a month ago.
Source https://www.king5.com/mobile/article/news/health/coronavirus...
Both sides would have notably different biases that would need to be accounted for, and would have different guidelines for FDA approval. Pausing the project when you discover there was a miscommunication over what kind of testing was being done makes sense. You need to keep the potentially tricky data separate from further results.
>Regardless, it has nothing to do with the TFA and the FDA's actions.
It's the actual reason they gave for their actions, and their request for more information on tests done to people not showing symptoms would be one of the main things they need to determine what bias is present.
https://marginalrevolution.com/marginalrevolution/2020/03/em...
“By Feb. 25, Dr. Chu and her colleagues could not bear to wait any longer. They began performing coronavirus tests, without government approval.
What came back confirmed their worst fear. They quickly had a positive test from a local teenager with no recent travel history. The coronavirus had already established itself on American soil without anybody realizing it.”
Combined with symptoms taking about a week to present, this was in community spread for a while. Yet, here in WA, the deaths figure is still 92% over sixty years old. I don't know the percent from long term care facilities. (I would love that stat.)
Then the question is at what point did it break into long term care facilities? And could we have done something to strengthen their protection?
With a further question of what, exactly, causes it to go severe.
Citation needed. As far as I can tell, his only healthcare related holding is Schrodinger, Inc. which is new, and at 300M out of his 106B net worth could hardly be considered "much of his wealth" .
[0] - https://www.kiro7.com/news/local/bill-gates-says-foundation-...
> The two kinds of testing — surveillance and diagnostic — fall under different F.D.A. standards. In a pure surveillance study, the researchers may keep the results just for themselves. But coronavirus testing has largely revolved around getting results returned to doctors who can share the results with patients.
> “We had previously understood that SCAN was being conducted as a surveillance study,” the spokesperson said.
...
> Dr. Topol said it would not make sense to have people swab their noses and then not give them their test results.
> “To withhold that information from people is downright absurd,” Dr. Topol said.
While I agree with the sentiment, the 23andme situation provides a useful counter balance: if you provide untrained people with inaccurate results, is that better or worse?
In the 23andme case there was a worry that people might commit suicide or make massive life changes, if they discovered they had a potential terminal illness. Here, the 2x2 matrix of positive vs negative and true vs false, seems most dangerous on the false-positive side for people who believe it grants them freedom to do whatever they like. False negatives are dangerous for those who then feel certain they don’t have the disease currently and thus expose others unwittingly (but this is already likely!).
So I dunno, I bet they’ll review this somewhat quickly (the group sent their FDA materials in a few weeks ago according to the article) particularly once they have a tighter estimate on the false positive and negative rates.
So you suggest it's better to not test people?
For example, a PhD biologist friend of mine agonized for months before she was willing to look at her personal 23-and-me results, after the FDA certified them as accurate enough to show to consumers.
It's a real problem for everyone.
In addition, the informed consent form for participants has included language that results might be shared since early March: https://pastebin.com/wj6fMnrw So the FDA, in May, claiming to think the study was only surveillance suggests to me a remarkable failing of comprehension by the FDA.
> The FDA has not raised any concerns regarding the safety and accuracy of SCAN’s test
> We have been in conversation with the FDA since March 1st and hope to have our EUA soon. We initiated the process to authorize our lab-developed test and self-swab kit on March 23rd and, in accordance with the EUA process and timeline, submitted data to secure federal authorization on April 13th. We are actively working to address their questions and resume testing as soon as possible.
> We have performed internal studies to determine shipping and specimen stability with our assay, testing approximately 17,000 home-collected mid-turbinate swabs from both adults and children—including Seattle Flu Study and SCAN samples. We have provided the following information to the FDA:
> To date, only a single, minor adverse event has been reported.
> Our shipping and stability studies have established that detection of SARS-CoV-2 is stable for over a week at high and low regional temperatures.
> With regard to proper specimen collection outside of a clinical setting, our experience from more than 18 months of sampling with the Seattle Flu Study and now SCAN also shows a low rate of insufficient nasal sampling. The internal control in our assay readily identifies whether a sufficient specimen is collected.
> Numerous scientific studies have established similar rates of detection for mid-turbinate swabs and the nasal pharyngeal swabs typically used in clinical testing, including for SARS-CoV-2 detection. The Infectious Diseases Society of America (IDSA) guidelines endorse the use of mid-turbinate swabs and reference the potential for self-collection with appropriate instructions.
I agree with this part. As to the rest, I am not a lawyer.
[1]: https://www.encyclopedia.com/science/encyclopedias-almanacs-...
Using the Defense Production Act to order meat plants open (and thus prevent states from taking action to close them or make them safer if they are to remain open in the light of massive outbreaks at many of them.)
I think it's fair to lay it directly on his doorstep considering the person running the FDA currently is someone he directly appointed.
https://www.businessinsider.com/donald-trump-coronavirus-res...
If you have a false negative, then maybe they spread the disease more than they might have otherwise (unwittingly, but now with the “certainty” they don’t have it).
If you have a false positive, the main downside is from people who think “great, I’ve had it / got it, I’ll be immune shortly”. So that’s the main risk to them.
The false negative hypothesis is facile; even if you don't have it, you can still get it. Ignoring social distancing on that basis wouldn't be any more sensible than doing so without the test. To the extent that some people are just idiots, a false negative diagnosis does not change that.
I have noticed that your comment is quite typical for people who want to say that we live in a post-truth world. There are certainly problems, but one solution is to double down on science.
> we should [not] be ... trading insults.
A backhanded compliment is a form of insult, friend. I don't think this kind of ad hominem attack is substantially responsive to my remarks.
Your use of "my friend" is similar to the thing you're complaining about. I got what you mean. Bringing up "ad hominem" is dodging the real issue.
Another comment of yours: "utterly stupid bureaucracy"
https://www.nytimes.com/2020/04/17/technology/bill-gates-vir...
Yes there is. If the test fails, and they report to the patient that they do/don't have the virus, that can cause significant harm to the patient and others. We don't know how accurate these tests are, which is why a surveillance test is needed. (Or different standards would allow a diagnostic test, I'm not sure)
Tests do not inject you with any form of matter or fluid. Why are we completely halting testing, even if it is only 1/3 correct? Just disclose that fact to the testee and/or use 3 tests for a statistically significant result.
Does this reek of backdoor capitalism (corruption)?
Edit: adding sources 0: https://www.reuters.com/article/us-health-coronavirus-ethano...
1: https://www.snopes.com/fact-check/trump-admin-seizing-ppe/
2: https://www.politico.com/news/2020/04/03/strategic-national-...
> In one case, the FDA said it had found significant levels of the carcinogen acetaldehyde in ethanol supplied by a company for use in hand sanitizer, according to a recent email exchange seen by Reuters.
Is anyone surprised that using fuel ethanol might not be a good idea for hand sanitizer?
Doesn't really sound like a problem in a topical solution like hand sanitizer given people ingest it regularly.
Edit: Here's the current guidance (may not be the same as from the time of that article): https://www.fda.gov/regulatory-information/search-fda-guidan...
I don't see any explicit guidance on Acetaldehyde. The requirements show 95% ethanol for ethanol-based sanitizer, with a footnote saying actually, "Lower ethanol content alcohol falls within this policy so long as it is labeled accordingly, and the finished hand sanitizer meets the ethanol concentration of 80%."
It goes on to add, "Ethanol produced in facilities normally producing fuel or technical grade may be considered for use if the ethanol is produced from fermentation and distillation as would be typically used for consumable goods, and no other additives or other chemicals have been added to the ethanol. ... Because of the potential for the presence of potentially harmful impurities due to the processing approach, fuel or technical grade ethanol should only be used if it meets USP or FCC grade requirements and the ethanol has been screened for any other potentially harmful impurities not specified in the USP or FCC requirements."
Edit2: Here's the USP guidance on hand sanitizer, which lists Not More Than 10uL/L Acetaldehyde / Ethanol: https://www.usp.org/sites/default/files/usp/document/health-... Again, it's an ordinary metabolite of ethanol in the body, so this is probably pretty conservative.
Wikipedia notes, "After intravenous injection, the half-life in the blood is approximately 90 seconds." https://en.wikipedia.org/wiki/Acetaldehyde#Exposure_limits and "According to European Commission's Scientific Committee on Consumer Safety's (SCCS) "Opinion on Acetaldehyde" (2012) the cosmetic products special risk limit is 5 mg/l."
So, please add a point to your discourse. In my opinion, FDA did more good than bad for population of US in that particular case.
Not exactly right now, but anywhere in history of FDA.
You could do independent tests, though, again it is complicated. The causal factor for the false positive is probably correlated between tests. Such that the math will be more complicated than just the inverse of any false positive rate. (Though, mayhap that is good enough.)
Then when labs are running this test, they have very poor correlation studies that are essentially useless. Everyone is trying to rush these tests out the door.
I agree that they should start running them at scale, but all the data needs to be centralized and analyzed. They also need to bring in a lot of previously RNA tested positive COVID patients and see how many test positive.
The problem with all these fragmented efforts with 100 different tests is that we never get the full picture or a good sample pool. I think the FDA does need to apply the brakes here a bit and get this going.